Found 184 matching trials
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome. PHASE3 Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Show More Learn More & Join Trial
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome PHASE2 The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects PHASE1 The primary objective of this study is to assess the pharmacodynamic (PD) e...
Show More Learn More & Join Trial
Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS PHASE4 A prospective, randomised, open label study of 3 clinically licensed treatm...
Show More Location
East and North Hertfordshire NHS Trust
Learn More & Join Trial
Genotype Guided Antiplatelet Therapy In Ischemic Stroke NA A fifth of ischemic stroke or transient ischemic attack (TIA) patients will...
Show More Status
Active Not Recruiting
Location
Singapore General Hospital
Learn More & Join Trial
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) PHASE3 The main objective of this study is to compare a Dual Antithrombotic Therap...
Show More Learn More & Join Trial
Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent NA To compare the clinical outcomes of P2Y12 antagonist monotherapy with aspir...
Show More Location
Gangnam Severance Hospital
Learn More & Join Trial
Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI PHASE4 Clopidogrel is the P2Y12 inhibitor of choice in PCI patients requiring OAC....
Show More Location
University of Florida
Learn More & Join Trial
A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS PHASE4 The purpose of this study is to test the hypothesis that the onset of the a...
Show More Learn More & Join Trial
OCT or Angiography Guided De-escalation of DAPT EARLY_PHASE1 Optical coherence tomography (OCT) offers a high-resolution intravascular i...
Show More Location
Northern Hospital
Learn More & Join Trial